These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31729155)
1. Extracellular vesicles derived from injured vascular tissue promote the formation of tertiary lymphoid structures in vascular allografts. Dieudé M; Turgeon J; Karakeussian Rimbaud A; Beillevaire D; Qi S; Patey N; Gaboury LA; Boilard É; Hébert MJ Am J Transplant; 2020 Mar; 20(3):726-738. PubMed ID: 31729155 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic exosome-like vesicles regulate endothelial gene expression, inflammatory signaling, and function through the NF-κB signaling pathway. Migneault F; Dieudé M; Turgeon J; Beillevaire D; Hardy MP; Brodeur A; Thibodeau N; Perreault C; Hébert MJ Sci Rep; 2020 Jul; 10(1):12562. PubMed ID: 32724121 [TBL] [Abstract][Full Text] [Related]
3. The 20S proteasome core, active within apoptotic exosome-like vesicles, induces autoantibody production and accelerates rejection. Dieudé M; Bell C; Turgeon J; Beillevaire D; Pomerleau L; Yang B; Hamelin K; Qi S; Pallet N; Béland C; Dhahri W; Cailhier JF; Rousseau M; Duchez AC; Lévesque T; Lau A; Rondeau C; Gingras D; Muruve D; Rivard A; Cardinal H; Perreault C; Desjardins M; Boilard É; Thibault P; Hébert MJ Sci Transl Med; 2015 Dec; 7(318):318ra200. PubMed ID: 26676607 [TBL] [Abstract][Full Text] [Related]
4. The Impact of Programmed Cell Death on the Formation of Tertiary Lymphoid Structures. Dieudé M; Kaci I; Hébert MJ Front Immunol; 2021; 12():696311. PubMed ID: 34335608 [TBL] [Abstract][Full Text] [Related]
5. The perlecan fragment LG3 is a novel regulator of obliterative remodeling associated with allograft vascular rejection. Soulez M; Pilon EA; Dieudé M; Cardinal H; Brassard N; Qi S; Wu SJ; Durocher Y; Madore F; Perreault C; Hébert MJ Circ Res; 2012 Jan; 110(1):94-104. PubMed ID: 22076637 [TBL] [Abstract][Full Text] [Related]
6. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
7. Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis. Wang M; Rajkumar S; Lai Y; Liu X; He J; Ishikawa T; Nallapothula D; Singh RR Front Immunol; 2023; 14():1204777. PubMed ID: 38022566 [TBL] [Abstract][Full Text] [Related]
8. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. Motallebzadeh R; Rehakova S; Conlon TM; Win TS; Callaghan CJ; Goddard M; Bolton EM; Ruddle NH; Bradley JA; Pettigrew GJ FASEB J; 2012 Jan; 26(1):51-62. PubMed ID: 21926237 [TBL] [Abstract][Full Text] [Related]
9. Asialo GM1 positive CD8+ T cells induce skin allograft rejection in the absence of the secondary lymphoid organs. Yamanokuchi S; Ikai I; Nishitai R; Matsushita T; Sugimoto S; Shiotani T; Yamaoka Y J Surg Res; 2005 Nov; 129(1):57-63. PubMed ID: 16140338 [TBL] [Abstract][Full Text] [Related]
10. The perlecan fragment LG3 regulates homing of mesenchymal stem cells and neointima formation during vascular rejection. Pilon EA; Dieudé M; Qi S; Hamelin K; Pomerleau L; Beillevaire D; Durocher Y; Zutter M; Coutu D; Perreault C; Hébert MJ Am J Transplant; 2015 May; 15(5):1205-18. PubMed ID: 25808553 [TBL] [Abstract][Full Text] [Related]
11. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Bishop DK; Shelby J; Eichwald EJ Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070 [TBL] [Abstract][Full Text] [Related]
12. Preliminary findings in corneal allograft rejection in patients with keratoconus. Hargrave S; Chu Y; Mendelblatt D; Mayhew E; Niederkorn J Am J Ophthalmol; 2003 Apr; 135(4):452-60. PubMed ID: 12654360 [TBL] [Abstract][Full Text] [Related]
13. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury. Cardinal H; Dieudé M; Brassard N; Qi S; Patey N; Soulez M; Beillevaire D; Echeverry F; Daniel C; Durocher Y; Madore F; Hébert MJ Am J Transplant; 2013 Apr; 13(4):861-874. PubMed ID: 23432943 [TBL] [Abstract][Full Text] [Related]
14. Tertiary lymphoid tissues generate effector and memory T cells that lead to allograft rejection. Nasr IW; Reel M; Oberbarnscheidt MH; Mounzer RH; Baddoura FK; Ruddle NH; Lakkis FG Am J Transplant; 2007 May; 7(5):1071-9. PubMed ID: 17359505 [TBL] [Abstract][Full Text] [Related]
15. Characterizing the B-Cell and Humoral Response in Tertiary Lymphoid Organs in Kidney Allografts. Nowocin AK; Meader L; Brown K; Elgueta R; Wong W Exp Clin Transplant; 2019 Jun; 17(3):330-338. PubMed ID: 30880652 [TBL] [Abstract][Full Text] [Related]